Probabilistic sensitivity analysis of apxiaban versus warfarin.

<p>Probabilistic sensitivity analysis of apxiaban versus warfarin.</p

Data sources for Markov cohort simulation.

<p>ARISTOTLE: Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; CDARS: Clinical Data Analysis and Reporting System of Hong Kong; NVAF: non-valvular atrial fibrillation.</p

Tornado diagram of apixaban versus warfarin.

<p>Tornado diagram of apixaban versus warfarin.</p

Health and cost outcome estimations in base-case analysis.

<p>Health and cost outcome estimations in base-case analysis.</p

Demographic and clinical profiles of patients with NVAF in CDARS 2010–13.

<p>Demographic and clinical profiles of patients with NVAF in CDARS 2010–13.</p